Charles River Laboratories is a full-service, early-stage contract research organization. It supports the drug discovery efforts of the biotech industry from target identification through nonclinical development. During the nonclinical stage, a drug candidate is tested in vitro (typically on a cellular or subcellular level in a test tube) and in vivo (in animal research models) to support human clinical trials. CRL provides services in basic research, drug discovery, safety and efficacy assessment, clinical support, and manufacturing for a wide range of pharmaceutical and biotech customers. The company is headquartered in Wilmington, Massachusetts and has facilities in the U.S. and overseas.
David H. ToungSenior Analyst: Medical Devices & Healthcare Services